visualizations
Mckenzie, Nathalie Dauphin, MD, MSPH
Overview
overview
- Natalie Dauphin McKenzie, MD, MSPH, is a board-certified gynecologic oncologist with a breadth of experience providing advanced treatments including minimally invasive and robotic-assisted procedures for women with all types of gynecologic cancer. She earned her medical degree with research honors at the University of New York at Buffalo and undertook her residency training and fellowship at the University of Miami/Jackson Memorial Hospital. She also earned her Master of Science in Public Health with honors while completing her fellowship training. Dr. McKenzie is an award-winning physician who is known for her expertise in radical debulking procedures for removing advanced tumors. She is particularly interested in HPV-related neoplasia and patient-driven cancer treatment. She is also a multilingual provider with fluency in English, French, medical Spanish and Haitian Creole.
research areas
Affiliation
Member of
-
Clinical Program
-
Research Department
Publications
Most Recent Publications
-
2024Neoadjuvant chemotherapy with bevacizumab for locally advanced vulvar cancer. INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER. 34:977-984.Full Text via DOI: 10.1136/ijgc-2024-005402 PMID: 38830645
-
2023Rapid recurrence of stage IIB non-gestational ovarian choriocarcinoma with minor yolk sac tumor: A rare case report and literature review. GYNECOLOGIC ONCOLOGY REPORTS.Full Text via DOI: 10.1016/j.gore.2023.101312 PMID: 38075548
-
2023Prognostic features of the tumor microenvironment in high-grade serous ovarian cancer and dietary immunomodulation. LIFE SCIENCES.Full Text via DOI: 10.1016/j.lfs.2023.122178 PMID: 37839778
-
2023Clinical outcomes analysis of neoadjuvant chemotherapy for locally advanced vulvar cancer. GYNECOLOGIC ONCOLOGY. S97-S97.Full Text via DOI: 10.1016/j.ygyno.2023.06.055
-
2023Analysis of "sandwich" chemo-radiation therapy for stage IIIC endometrial cancer. GYNECOLOGIC ONCOLOGY. S143-S143.Full Text via DOI: 10.1016/j.ygyno.2023.06.132
-
2023Malignant peritoneal cytologic contamination with robotic hysterectomy for endometrial cancer. GYNECOLOGIC ONCOLOGY. 175:93-96.Full Text via DOI: 10.1016/j.ygyno.2023.06.006 PMID: 37329874
-
2023Clinical Activity of Olvimulogene Nanivacirepvec-Primed Immunochemotherapy in Heavily Pretreated Patients With Platinum-Resistant or Platinum-Refractory Ovarian Cancer The Nonrandomized Phase 2 VIRO-15 Clinical Trial. JAMA ONCOLOGY. 9:903-908.Full Text via DOI: 10.1001/jamaoncol.2023.1007 PMID: 37227734
-
2022CERVICAL CANCER TREATED BY NEOADJUVANT CHEMOTHERAPY FOLLOWED BY RADICAL SURGERY: A CASE SERIES FROM MIREBALAIS, HAITI. INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER. A81-A81.Full Text via DOI: 10.1136/ijgc-2022-igcs.172
-
2022Exploring Bias in Scientific Peer Review: An ASCO Initiative. JCO ONCOLOGY PRACTICE. 791-+.Full Text via DOI: 10.1200/OP.22.00275 PMID: 36215686
-
2022Fused Clitoral Hood Presenting as a Periclitoral Mass. OBSTETRICS AND GYNECOLOGY. 140:1056-1060.Full Text via DOI: 10.1097/AOG.0000000000004996 PMID: 36357995
-
2022MALIGNANT PERITONEAL CYTOLOGIC CONTAMINATION WITH ROBOTIC HYSTERECTOMY FOR ENDOMETRIAL CANCER. INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER. A93-A93.Full Text via DOI: 10.1136/ijgc-2022-igcs.204
-
2022Impact of Lifestyle Interventions on Gynecologic Cancers: Beyond Diet and Exercise. AMERICAN JOURNAL OF LIFESTYLE MEDICINE.Full Text via DOI: 10.1177/15598276221123764
-
2022Single-Institution Retrospective Analysis of Ovarian Cancer Outcomes from the Middle Eastern Republic of Georgia. INDIAN JOURNAL OF GYNECOLOGIC ONCOLOGY. 20.Full Text via DOI: 10.1007/s40944-022-00618-z
-
2022Immunotherapy in the Treatment of Platinum-Resistant Ovarian Cancer: Current Perspectives. ONCOTARGETS AND THERAPY. 853-866.Full Text via DOI: 10.2147/OTT.S335936 PMID: 35982728
-
2021ASO Visual Abstract: Carcinomatosis in Early-Stage Cervical Cancer Treated with Robotic Radical Hysterectomy-Recurrence Patterns, Risk Factors, and Survival. ANNALS OF SURGICAL ONCOLOGY.Full Text via DOI: 10.1245/s10434-021-11148-x PMID: 34850304
-
2021Carcinomatosis in Early-Stage Cervical Cancer Treated with Robotic Radical Hysterectomy: Recurrence Patterns, Risk Factors, and Survival. ANNALS OF SURGICAL ONCOLOGY.Full Text via DOI: 10.1245/s10434-021-11052-4 PMID: 34757549
-
2021Neoadjuvant chemotherapy followed by fertility sparing surgery in cervical cancers size 2-4 cm; emerging data and future perspectives. GYNECOLOGIC ONCOLOGY. 809-815.Full Text via DOI: 10.1016/j.ygyno.2021.06.006 PMID: 34130862
-
2021Isolated vulvar Langerhans cell histiocytosis. GYNECOLOGIC ONCOLOGY REPORTS. 36.Full Text via DOI: 10.1016/j.gore.2021.100785 PMID: 34036139
-
2021Phase 1 trial of nelfinavir added to standard cisplatin chemotherapy with concurrent pelvic radiation for locally advanced cervical cancer. CANCER. 127:2279-2293.Full Text via DOI: 10.1002/cncr.33449 PMID: 33932031
-
2021The gut microbiome and cancer immunotherapeutics: A review of emerging data and implications for future gynecologic cancer research. CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY.Full Text via DOI: 10.1016/j.critrevonc.2020.103165 PMID: 33227575
-
2020FREQUENCY AND MOLECULAR ASSOCIATIONS OF KRAS MUTATIONS IN GYNECOLOGIC MALIGNANCIES. INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER. A158-A159.
-
2020ONCOLYTIC VACCINIA (OLVI-VEC) PRIMED IMMUNOCHEMOTHERAPY IN PLATINUM-RESISTANT/REFRACTORY OVARIAN CANCER. INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER. A9-A10.Full Text via DOI: 10.1136/ijgc-2020-IGCS.12
-
2020Phase II VIRO-15 trial of olvimulogene nanivacirepvec (Olvi-Vec)-primed immunochemotherapy in platinum-resistant/refractory ovarian cancer (PRROC) (NCT02759588). GYNECOLOGIC ONCOLOGY. 60-60.Full Text via DOI: 10.1016/j.ygyno.2020.06.126
-
2020The effect of intraperitoneal chemotherapy after interval cytoreductive surgery on recurrence and survival in patients with advanced-stage ovarian carcinoma. GYNECOLOGIC ONCOLOGY. 154-154.Full Text via DOI: 10.1016/j.ygyno.2020.05.219
-
2020Phase II trial of oncolytic vaccinia virus primed immunochemotherapy in platinum-resistant/refractory ovarian cancer (PRROC) (NCT02759588). ANNALS OF ONCOLOGY. S628-S628.Full Text via DOI: 10.1016/j.annonc.2020.08.976
-
2020Robotic sentinel lymph node (SLN) mapping in endometrial cancer: SLN symmetry and implications of mapping failure. INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER. 30:305-310.Full Text via DOI: 10.1136/ijgc-2019-000915 PMID: 31857439
-
2020Empowering and training front-line providers treating cervical cancer in Haiti: perspective of a gynecologic oncologist's experience with international surgical missions. INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER. 274-275.Full Text via DOI: 10.1136/ijgc-2019-000758 PMID: 31451561
-
2019FACTORS ASSOCIATED WITH EXTENDED SURVIVAL FOR PATIENTS WITH PLATINUM-RESISTANT OVARIAN CANCER (PROC) TREATED WITH MODIFIED VACCINIA ONCOLYTIC VIROTHERAPY (VOV). INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER. A58-A58.Full Text via DOI: 10.1136/ijgc-2019-IGCS.120
-
2019Sentinel lymph nodes (SLN) in endometrial cancer: The relationship between primary tumor histology, SLN metastasis size, and non-sentinel node metastasis. GYNECOLOGIC ONCOLOGY. 154:53-59.Full Text via DOI: 10.1016/j.ygyno.2019.04.654 PMID: 31027899
-
2019Timing of postoperative Foley catheter removal fromrobotic-assisted radical hysterectomy in patients with early-stage cervical cancer. GYNECOLOGIC ONCOLOGY. 157-157.Full Text via DOI: 10.1016/j.ygyno.2019.04.369
-
2019
-
2018Fertility preserving options for gynecologic malignancies: A review of current understanding and future directions. CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY. 116-124.Full Text via DOI: 10.1016/j.critrevonc.2018.09.020 PMID: 30447916
-
2018Poster Session Paraaortic lymph node dissection pathology in patients with endometrial cancer undergoing robotic sentinel lymph node mapping (SLNM). GYNECOLOGIC ONCOLOGY. 109-109.Full Text via DOI: 10.1016/j.ygyno.2018.04.252
-
2018Recurrence patterns and survival in patients with endometrial cancer undergoing robotic sentinel lymph node mapping (SLNM). GYNECOLOGIC ONCOLOGY. 108-108.Full Text via DOI: 10.1016/j.ygyno.2018.04.249
-
2018Novel Treatment of Small-Cell Neuroendocrine of the Vagina. CASE REPORTS IN ONCOLOGICAL MEDICINE.Full Text via DOI: 10.1155/2018/9157036 PMID: 29535879
-
2014HPV in HIV-infected women: implications for primary prevention. FRONTIERS IN ONCOLOGY. 4.Full Text via DOI: 10.3389/fonc.2014.00179 PMID: 25161956
-
2010Assessing the acceptability of self-sampling for HPV among Haitian immigrant women: CBPR in action. CANCER CAUSES & CONTROL. 21:421-431.Full Text via DOI: 10.1007/s10552-009-9474-0 PMID: 19943103
-
2010Women with HIV are more commonly infected with non-16 and-18 high-risk HPV types. GYNECOLOGIC ONCOLOGY. 572-577.Full Text via DOI: 10.1016/j.ygyno.2009.10.058 PMID: 19906410
-
2010One Size Does Not Fit All: Differences in HPV Knowledge between Haitian and African American Women. CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION. 19:366-370.Full Text via DOI: 10.1158/1055-9965.EPI-09-1180 PMID: 20142238
Background
Full Name
- Nathalie Dauphin Mckenzie, MD
Education
- University of New York at Buffalo School of Medicine, Buffalo, NY
Residency
- Memorial Sloan Kettering Cancer Center, NY
Fellowship
- University of Miami/ Jackson Memorial Hospital, Miami, FL
Board Certification
- American Board of Obstetrics and Gynecology
Contact
primary email
- Research.Institute@AdventHealth.com